Information for "Recognition regarding point IIIA melanoma sufferers with highrisk with regard to disease relapse utilizing a clinicopathologic and gene expression product"
From EECH Central
Basic information
| Display title | Recognition regarding point IIIA melanoma sufferers with highrisk with regard to disease relapse utilizing a clinicopathologic and gene expression product |
| Default sort key | Recognition regarding point IIIA melanoma sufferers with highrisk with regard to disease relapse utilizing a clinicopathologic and gene expression product |
| Page length (in bytes) | 3,638 |
| Page ID | 1378201 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Stoolbuffet43 (Talk | contribs) |
| Date of page creation | 15:08, 18 April 2024 |
| Latest editor | Stoolbuffet43 (Talk | contribs) |
| Date of latest edit | 15:08, 18 April 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
